Related Experiment Videos
Allelotype analysis of the PTEN, Smad4 and DCC genes in biliary tract cancer
Takayuki Suto1, Tamotsu Sugai, Wataru Habano
1Department of Surgery I, School of Medicine, Iwate Medical University, Morioka, Japan.
Abstract:
Aberrations of the PTEN, Smad4 and DCC genes have not been determined in biliary tract cancers. We performed allelotype analysis to screen for alterations of these genes. We looked for the presence of allelic imbalance (AI) at the PTEN and Smad4 genes in extrahepatic bile duct (EHBD) and ampullary cancers using polymorphic microsatellite markers. These tumors were also examined for AI at the DCC gene using polymerase chain reaction amplification of variable numbers of tandem repeats. AI at the PTEN, Smad4 and DCC genes was observed in 5.3%, 8.3% and 20.7%, respectively, of EHBD tumor cases. AI at the PTEN, Smad4 and DCC genes was detected in 13.3%, 50% and 8.3%, respectively, of ampullary cancer cases. Our results suggest that (a) alteration of the Smad4 gene is a major factor in the development of ampullary cancer and (b) PTEN, Smad4 and DCC genes are altered infrequently in EHBD cancers.
Insights
Genetic alterations in PTEN, Smad4, and DCC genes were analyzed in biliary tract cancers. Smad4 gene alterations are significant in ampullary cancer development, while PTEN, Smad4, and DCC genes are infrequently altered in extrahepatic bile duct cancers.
Area of Science:
- Oncology
- Cancer Genetics
- Molecular Biology
Background:
- Aberrations in PTEN, Smad4, and DCC genes are not well-characterized in biliary tract cancers.
- Understanding these genetic alterations is crucial for elucidating cancer development pathways.
Purpose of the Study:
- To investigate the frequency and patterns of allelic imbalance (AI) in PTEN, Smad4, and DCC genes in extrahepatic bile duct (EHBD) and ampullary cancers.
- To determine the role of these gene alterations in the pathogenesis of biliary tract cancers.
Main Methods:
- Allelotype analysis was performed on tumor samples.
- Polymorphic microsatellite markers were used to detect AI at PTEN and Smad4 genes.
- Polymerase chain reaction amplification of variable numbers of tandem repeats was employed to assess AI at the DCC gene.
Main Results:
- AI at PTEN, Smad4, and DCC genes was observed in 5.3%, 8.3%, and 20.7% of EHBD tumors, respectively.
- AI at PTEN, Smad4, and DCC genes was detected in 13.3%, 50%, and 8.3% of ampullary cancer cases, respectively.
- Smad4 gene alteration was significantly more frequent in ampullary cancers (50%) compared to EHBD cancers (8.3%).
Conclusions:
- Alteration of the Smad4 gene appears to be a major contributing factor in the development of ampullary cancer.
- PTEN, Smad4, and DCC genes are infrequently altered in extrahepatic bile duct cancers, suggesting different molecular mechanisms in these tumor types.